Prevalence of high and low serum alkaline phosphatase levels and the associated factors in patients with rheumatoid arthritis: Results from the IORRA cohort study
Modern Rheumatology · 2024
DOI: 10.1093/mr/roae025 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Modern Rheumatology, 2024. Verfasst von Takefumi Furuya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Alkaline Phosphatase, Arthritis, Rheumatoid. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
- Institute of Rheumatology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
- Wakabayashi Clinic, Tokyo, Japan.
- Showa University Research Administration Center, Showa University, Tokyo, Japan.
- Department of Rheumatology, Sanno Medical Center, Tokyo, Japan.
ORCID-Profile: Takefumi Furuya
Zitieren
APA
Furuya, T., Inoue, E., Tanaka, E., Yamanaka, H., & Harigai, M. (2024). Prevalence of high and low serum alkaline phosphatase levels and the associated factors in patients with rheumatoid arthritis: Results from the IORRA cohort study. Modern Rheumatology. https://doi.org/10.1093/mr/roae025
Vancouver
Furuya T, Inoue E, Tanaka E, Yamanaka H, Harigai M. Prevalence of high and low serum alkaline phosphatase levels and the associated factors in patients with rheumatoid arthritis: Results from the IORRA cohort study. Modern Rheumatology. 2024. doi:10.1093/mr/roae025
BibTeX
@article{Furuya2024,
author = {Furuya, Takefumi and Inoue, Eisuke and Tanaka, Eiichi and Yamanaka, Hisashi and Harigai, Masayoshi},
title = {Prevalence of high and low serum alkaline phosphatase levels and the associated factors in patients with rheumatoid arthritis: Results from the IORRA cohort study},
journal = {Modern Rheumatology},
year = {2024},
doi = {10.1093/mr/roae025}
}
EUVIMED